326.7500 -5.45 (-1.64%)
NSE Sep 04, 2026 15:31 PM
Volume: 1.7M
 

326.75
-1.64%
Dynamic Levels
Marksans R&D; capabilities include dossier development, chemical synthesis, process optimization, formulation development, analytical development and conducting stability studies. The company has a team of over 50 experienced scientists specializing in formulation development and analytical development. The conpany has possessed end-to-end capabilities from Lab scale development to Pilot scale up and from commercializing the product for large...
Marksans Pharma has gained 90.85% in the last 6 Months
More from Marksans Pharma Ltd.
Recommended